Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia

Psychiatry Research

Volumn 185, Issue 1-2, 2011, Pages 129-134

  Jaworski, Fabienne ^a   Dubertret, Caroline ^a,b,c   Adès, Jean ^a,c   Gorwood, Philip ^b,c  

^a HÔPITAL LOUIS MOURIER   (France)

^b CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bipolar disorder; Co morbidity; Schizophrenia; Social adaptation; Substance use disorder

Indexed keywords

ALCOHOL; CANNABIS;

ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CRIMINAL BEHAVIOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RISK FACTOR; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL INTERACTION; SUBSTANCE ABUSE; SUICIDE ATTEMPT;

ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; SUBSTANCE-RELATED DISORDERS; SUICIDE, ATTEMPTED;

EID: 78650180905     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.06.005     Document Type: Article

References (50)

1. Addington J., Addington D. Substance abuse and cognitive functioning in schizophrenia. Journal of Psychiatry & Neuroscience 1997, 22:99-104.
2. Angst J., Sellaro R. Historical perspectives and natural history of bipolar disorder. Biological Psychiatry 2000, 48:445-457.
3. Baethge C., Baldessarini R.J., Khalsa H.M., Hennen J., Salvatore P., Tohen M. Substance abuse in first-episode bipolar I disorder: indications for early intervention. The American Journal of Psychiatry 2005, 162:1008-1010.
4. Blairy S., Linotte S., Souery D., Papadimitriou G.N., Dikeos D., Lerer B., Kaneva R., Milanova V., Serretti A., Macciardi F., Mendlewicz J. Social adjustment and self-esteem of bipolar patients: a multicentric study. Journal of Affective Disorders 2004, 79(1-3):97-103.
5. Boylan K.R., Bieling P.J., Marriott M., Begin H., Young L.T., MacQueen G.M. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. The Journal of Clinical Psychiatry 2004, 65:1106-1113.
6. Brady, K., Sonne, S., 1995. The relationship between substance abuse and bipolar disorder.
7. Coryell W., Scheftner W., Keller M., Endicott J. The enduring psychosocial consequences of mania and depression. The American Journal of Psychiatry 1993, 150:720-727.
8. Dalton E.J., Cate-Carter T.D., Mundo E., Parikh S.V., Kennedy J.L. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disorders 2003, 5(1):58-61.
9. Dixon L. Dual diagnostis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research 1999, 35:93-100.
10. Drake R.E., Xie H., McHugo G.J., Shumway M. Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders. Biological Psychiatry 2004, 56(10):749-756.
11. Falret Mémoire sur la folie circulaire. Bulletin de l'Académie Nationale de Médecine 1854, 19:384-415.
12. Feinman J., Dunner D. The effect of alcoholism and substance abuse on the course of bipolar affective disorder. Journal of Affective Disorders 1996, 37:43-49.
13. Fossey M.D., Otto M.W., Yates W.R., Wisniewski S.R., Gyulai L., Allen M.H., Miklowitz D.J., Coon K.A., Ostacher M.J., Neel J.L., Thase M.E., Sachs G.S., Weiss R.D. Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. The American Journal on Addictions 2006, 15(2):138-143. Step-BD Investigators.
14. Ghaemi S.N., Boiman E., Goodwin F.K. Insight and outcome in bipolar, unipolar, and anxiety disorders. Comprehensive Psychiatry 2000, 41(3):167-171.
15. Goodwin F., Jamison K. Manic-depressive Illness 1990, Oxford University Press, New York.
16. Hasin D., Endicott J., Lewis C. Alcohol and drug abuse in patients with affective syndromes. Comprehensive Psychiatry 1985, 26:283-295.
17. Hosmer D.W., Lemeshow S. A goodness-of-for test for the multiple logistic regression. Communications in Statistics 1980, A10:1043-1069.
18. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., Smith S.M., Goldstein R.B., Grant B.F. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the national epidemiologic survey on alcohol and related conditions. The Journal of Clinical Psychiatry 2006, 67(7):1062-1073.
19. Judd L.L., Akiskal H.S., Schettler P.J. The long-term natural history of weekly symptomatic status of bipolar disorder. Archives of General Psychiatry 2002, 59:530-537.
20. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Leon A.C., Solomon D.A., Coryell W., Maser J.D., Keller M.B. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Archives of General Psychiatry 2005, 62(12):1322-1330.
21. Judd L.L., Schettler P.J., Solomon D.A., Maser J.D., Coryell W., Endicott J., Akiskal H.S. Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. Journal of Affective Disorders 2008, 108(1-2):49-58.
22. Keck P.E., McElroy S.L., Strakowski S.M., West S.A., Sax K.W., Hawkins J.M., Boume M.L., Haggard P. Twelve-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. The American Journal of Psychiatry 1998, 155:646-652.
23. Keller M.B. Improving the course of illness and promoting continuation of treatment of bipolar disorder. Journal of Clinical Psychiatry 2004, 65(suppl 15):10-14.
24. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Archives of General Psychiatry 1994, 51(1):8-19.
25. Kilbourne A.M., Salloum I., Dausey D., Cornelius J.R., Conigliaro J., Xu X., Pincus H.A. Quality of care for substance use disorders in patients with serious mental illness. Journal of Substance Abuse Treatment 2006, 30(1):73-77.
26. Kusznir A., Cooke G.C., Trevor Young L. The correlates of community functioning in patients with bipolar disorder. Journal of Affective Disorders 2000, 61(1-2):81-85.
27. Manwani S.G., Szilagyi K.A., Zablotsky B., Hennen J., Griffin M.L., Weiss R.D. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. The Journal of Clinical Psychiatry 2007, 68:1172-1176.
28. Mason P., Harrison G., Glazebrook C., Medley I., Croudace T. The course of schizophrenia over 13 years: a report from the international study on schizophrenia (Isos) coordinated by the World Health Organisation. The British Journal of Psychiatry 1996, 169:580-586.
29. Mazza M., Mandelli L., Di Nicola M., Harnic D., Catalano V., Tedeschi D., Martinotti G., Colombo R., Bria P., Serretti A., Janiri L. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. Journal of Affective Disorder 2009, 11:527-535.
30. Mueser K.T., Bellack A.S., Morrison R.L., Wixted J.T. Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning. Journal of Psychiatry Research 1990, 24(1):51-63.
31. Nierenberg A.A., Miyahara S., Spencer T., Wisniewski S.R., Otto M.W., Simon N., Pollack M.H., Ostacher M.J., Ya L., Siege R., Sachs G.S. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biological Psychiatry 2005, 57:1467-1473. STEP-BD Investigators.
32. Nolen W.A., Luckenbaugh D.A., Altshuler L.L., Suppes T., McElroy S.L., Frye M.A., Kupka R.W., Keck P.E., Leverich G.S., Post R.M. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. The American Journal of Psychiatry 2004, 161(8):1447-1454.
33. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies: rational, unique features, and training. Archives of General Psychiatry 1994, 51:849-862.
34. O'Connell R.A., Mayo J.A., Flatow L., Cuthbertson B., O'Brien B.E. Outcome of bipolar disorder on long-term treatment with lithium. The British Journal of Psychiatry 1991, 159:123-129.
35. Otto M.W., Simon N.M., Wisniewski S.R., Miklowitz D.J., Kogan J.N., Reilly-Harrington N.A., Frank E., Nierenberg A.A., Marangell L.B., Sagduyu K., Weiss R.D., Miyahara S., Thas M.E., Sachs G.S., Pollack M.H. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. The British Journal of Psychiatry 2006, 189:20-25. STEP-BD Investigators.
36. Owen R.R., Fisher E.P., Booth B.M., Cuffel B.J. Medication non compliance and substance abuse among patients with schizophrenia. Psychiatric Services 1996, 47:853-858.
37. Preisig M., Fenton B.T., Matthey M.L., Berney A., Ferrero F. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. European Archives of Psychiatry and Clinical Neuroscience 1999, 249(4):174-179.
38. Regier D., Farmer M., Rae D., Loecke B.Z., Keith L.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse, results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association 1990, 264(19):2511-2518.
39. Salloum I.M., Thase M.E. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disorders 2000, 2:269-280.
40. Salloum I.M., Cornelius J.R., Mezzich J.E., Kirisci L. Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation. Bipolar Disorders 2002, 4(6):418-421.
41. Sentissi O., Navarro J.C., De Oliveira H., Gourion D., Bourdel M.C., Baylé F.J., Olié J.P., Poirier M.F. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients. Psychiatry Research 2008, 161(1):36-42.
42. Simon N.M., Otto M.W., Wisniewski S.R., Fossey M., Sagduyu K., Frank E., Sachs G.S., Nierenberg A.A., Thase M.E., Pollack M.H. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry 2004, 161(12):2222-2229.
43. Sonne S., Brady K., Morton W.A. Substance abuse and bipolar affective disorder. The Journal of Nervous and Mental Disease 1994, 182:349-352.
44. Strakowski S., DelBello M., Fleck D. The impact of substance abuse on the course of bipolar disorder. Biological Psychiatry 2000, 48:477-485.
45. Tamam L., Karakus G., Ozpoyraz N. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. European Archives of Psychiatry Clinical Neuroscience 2008, 258:385-393.
46. Taylor M.A., Abrams R. Manic depressive illness and good prognosis schizophrenia. The American Journal of Psychiatry 1975, 132:741-742.
47. Tohen M., Greenfield S., Weiss R., Zarate C., Vagge L.M. The effect of co-occurring substance use disorders on the course of bipolar disorders. Harvard Review of Psychiatry 1998, 6:133-141.
48. Weiss R.D., Najavits L.M., Greenfield S.F., Soto J.A., Shaw S.R., Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. The American Journal of Psychiatry 1998, 155(1):127-128.
49. Weiss R.D., Ostacher M.J., Otto M.W., Calabrese J.R., Fossey M., Wisniewski S.R., Bowden C.L., Nierenberg A.A., Pollack M.H., Salloum I.M., Simon N.M., Thase M.E., Sachs G.S. Does recovery from substance use disorder matter in patients with bipolar disorder?. The Journal of Clinical Psychiatry 2005, 66(6):730-735. for STEP-BD Investigators.
50. Weissman M.M., Bothwell S. Assessment of social adjustment by patient self-report. Archives of General Psychiatry 1976, 33(9):1111-1115.